Cover Image
Market Research Report

Computational Medicine and Drug Discovery Software Market: By Tools (Software, Databases and Others); By Application (Drug Discovery and Development, Disease Modeling, Medical Imaging and Others) & By Geography - 2019-2024

Published by IndustryARC Product code 351092
Published Content info
Delivery time: 2-3 business days
Price
Back to Top
Computational Medicine and Drug Discovery Software Market: By Tools (Software, Databases and Others); By Application (Drug Discovery and Development, Disease Modeling, Medical Imaging and Others) & By Geography - 2019-2024
Published: December 21, 2018 Content info:
Description

Computational Medicine and Drug Discovery Software, as the name suggests, is an interdisciplinary subject that goes for creating innovative solutions for important clinical problems to improve human health. There are many clinical applications of computational medicine which help in the process of data collection and development of tools for clinical decision making. Computational Medicine finds its roots in chemistry and quantum mechanics. The foundation of computational medicine is based upon database and constraint-based models. Database is basically repositories of information which is used in constraint-based models to understand protein-ligand interaction. The global market for computational medicine and drug discovery software was estimated to be $5.2 billion in 2015 and is projected to escalate to $7.1 billion by 2021.

The computational medicine and drug discovery software market has been extensively studied based on several differentiating parameters to provide a comprehensive overview. The market has been segmented based on following parameters: tools, application and geography. Each of the categories has been further segregated into specific sub-divisions to consider the dynamics associated with this industry. Based on tools, software remained pre-dominant choice in 2015 followed by database. The applications considered in the report include computational physiological medicine, drug discovery and development, medical imaging, disease modeling, predictive analysis of drug targets, cellular simulation and simulation software. A similar strategy was followed to investigate the industry dynamics for computational medicine and drug discovery software specific to eminent countries that constituted the overall regional market including Americas, Europe, Asia-Pacific (APAC) and Rest of the World (RoW).

In 2015, the market share for medical imaging was 38.3% and is projected to grow at a CAGR of 4.2% during the forecast period. The main driving factor for the market are rising bioinformatics in drug discovery, three dimensional drug discovery methodology evolution and increase in late stage drug discovery failure.

Some of the established players in the market include:

Compugen Ltd.

Certara, L.P.

Dassault Systemes

Schrodinger LLC

Genedata AG.

Table of Contents

1. Global Computational Medicine and Drug Discovery Software Market Overview

2. Executive Summary

3. Global Computational Medicine and Drug Discovery Software Market Landscape

  • 3.1. Market share Analysis
  • 3.2. Comparative Analysis
    • 3.2.1. Product Benchmarking
    • 3.2.2. End-User Profiling
    • 3.2.3. Patent Analysis
    • 3.2.4. Top 5 Financial Analysis

4. Global Computational Medicine and Drug Discovery Software - Market Forces

  • 4.1. Market Drivers
  • 4.2. Market Constraints
  • 4.3. Market Challenges
  • 4.4. Attractiveness of the Industry
    • 4.4.1. Power of Suppliers
    • 4.4.2. Power of Customers
    • 4.4.3. Threat of New entrants
    • 4.4.4. Threat of Substitution
    • 4.4.5. Degree of Competition

5. Global Computational Medicine and Drug Discovery Software Market - Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunity Analysis
  • 5.4. Product Life Cycle Analysis
  • 5.5. Suppliers & Distributors

6. Global Computational Medicine and Drug Discovery Software Market - By Tools

  • 6.1. Introduction
  • 6.2. Databases
  • 6.3. Software
  • 6.4. Others

7. Global Computational Medicine and Drug Discovery Software Market - By Application

  • 7.1. Introduction
  • 7.2. Computational Physiological Medicine
  • 7.3. Drug Discovery and Development
  • 7.4. Medical Imaging
  • 7.5. Disease Modelling
  • 7.6. Predictive Analysis of Drug Targets
  • 7.7. Cellular Simulation
  • 7.8. Simulation Software
  • 7.9. Others

8. Global Computational Medicine and Drug Discovery Software Market - By Geography

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. U.K.
    • 8.3.2. Germany
    • 8.3.3. Netherlands
    • 8.3.4. Norway
    • 8.3.5. Italy
    • 8.3.6. Others
  • 8.4. APAC
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. Korea
    • 8.4.4. Australia
    • 8.4.5. Others
  • 8.5. RoW

9. Market Entropy

  • 9.1. New Product Launches
  • 9.2. M&As, Collaborations, Partnerships & JVs

10. Investment Opportunities

11. Company Profiles

  • 11.1. Aurora Fine Chemicals LLC
  • 11.2. Biognos AB
  • 11.3. Certara, L.P.
  • 11.4. Chemical Computing Group Inc.
  • 11.5. CLC bio
  • 11.6. Collaborative Drug Discovery, Inc.
  • 11.7. Compugen Ltd.
  • 11.8. Crown Bioscience Inc.
  • 11.9. Dassault Systemes, BIOVIA Corp.
  • 11.10. Domainex Ltd
  • 11.11. Entelos, Inc.
  • 11.12. Genedata AG
  • 11.13. Leadscope, Inc.
  • 11.14. Nimbus Therapeutics
  • 11.15. Prosarix Ltd
  • 11.16. Quant Med LLC
  • 11.17. Quantum Pharmaceuticals
  • 11.18. Rhenovia Pharma Limited
  • 11.19. Simulations Plus, Inc.
  • 11.20. Schrodinger, LLC

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

12. Appendix

  • 12.1. Abbreviations
  • 12.2. Sources
  • 12.3. Research Methodology
  • 12.4. Bibliography
  • 12.5. Compilation of Expert Insights
  • 12.6. Disclaimer
Back to Top